Inventor · disambiguated record
Zhengrong Cui
Also filed as: CUI ZHENGRONG
9 granted patents·16 pending applications·104 citations·filing 2003–2024
83Inventor score
Files withUNIV TEXAS17PDS BIOTECHNOLOGY CORP2UNIV KENTUCKY RES FOUND2AUGMENTA BIOWORKS INC1MUMPER RUSSELL1
Top patents by PatentIndex Score
25 records- 0191US7303881B2Antigen delivery compositions and methods of usePDS BIOTECHNOLOGY CORP·Filed 2005·Granted Dec 4, 2007·97 cites·5 claims
- 0283US11219633B2Nucleobase analogue derivatives and their applicationsUNIV TEXAS·Filed 2019·Granted Jan 11, 2022·2 cites·20 claims
- 0383US10463684B2Nucleobase analogue derivatives and their applicationsUNIV TEXAS·Filed 2015·Granted Nov 5, 2019·3 cites·11 claims
- 0473US11883423B2Nucleobase analogue derivatives and their applicationsUNIV TEXAS·Filed 2022·Granted Jan 30, 2024·0 cites·20 claims
- 0570US7588764B2Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticlesUNIV KENTUCKY RES FOUND·Filed 2003·Granted Sep 15, 2009·2 cites·18 claims
- 0666US2008124350A1Nanoparticle-based vaccine delivery system containing adjuvantUNIV KENTUCKY RES FOUND·Filed 2008·Application pending·0 cites
- 0765US11696950B2Dry solid aluminum adjuvant-containing vaccines and related methods thereofUNIV TEXAS·Filed 2018·Granted Jul 11, 2023·0 cites·19 claims
- 0864US2023060631A1Dry liposome adjuvant-containing vaccines and related methods thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0962US2025242006A1Dry powder compositions comprising eukaryotic cells and method of their manufacture and useUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1061US2023112956A1Monoclonal antibody dry powdersUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1161US2023057155A1Dry liposome formulations and related methods thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1259US2024238401A1Solid composition, freeze-drying method and glass vialTAKEDA VACCINES INC·Filed 2022·Application pending·0 cites
- 1358US2023270668A1Dry formulations of anti-sars-cov-2 virus antibodies and compositions and methods of use thereofAUGMENTA BIOWORKS INC·Filed 2022·Application pending·0 cites
- 1456US2023115214A1Dry powder compositions of oil-in-water (o/w) emulsion adjuvanted vaccinesUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1553US2006189554A1Nanoparticle-Based vaccine delivery system containing adjuvantMUMPER RUSSELL·Filed 2003·Application pending·0 cites
- 1653US2024165045A1Dry powder formulations of nucleic acid lipid nanoparticlesUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1749US12271663B2Method for collaborative controlling networks resilience of unmanned cluster system, terminal, and storage medium thereofUNIV HEFEI TECHNOLOGY·Filed 2024·Granted Apr 8, 2025·0 cites·13 claims
- 1849US11529314B2Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agentsUNIV TEXAS·Filed 2018·Granted Dec 20, 2022·0 cites·22 claims
- 1949US2022023204A1Biologically active dry powder compositions and method of their manufacture and useUNIV TEXAS·Filed 2021·Application pending·0 cites
- 2049US2016144023A1Dry solid aluminum adjuvant-containing vaccines and related methods thereofUNIV TEXAS·Filed 2015·Application pending·0 cites
- 2149US2020384007A1Lipid nanoparticles containing pharmaceutical and/or nutraceutical agents and methods thereofUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2243US11918646B2Dry adjuvanted immune stimulating compositions and use thereof for mucosal administrationUNIV TEXAS·Filed 2018·Granted Mar 5, 2024·0 cites·11 claims
- 2338US2021386680A1Selectively cleavable therapeutic nanoparticlesUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2438US2013131008A1Lipophilic monophosphorylated derivatives and nanoparticlesUNIV TEXAS·Filed 2012·Application pending·0 cites
- 2529US2008131455A1Antigen Delivery Compositions And Methods Of UsePDS BIOTECHNOLOGY CORP·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhengrong Cui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →